349 related articles for article (PubMed ID: 30109588)
1. Effect and Safety of Huannao Yicong Formula () in Patients with Mild-to-Moderate Alzheimer's Disease: A Randomized, Double-Blinded, Donepezil-Controlled Trial.
Yang Y; Liu JP; Fang JY; Wang HC; Wei Y; Cao Y; Liu JG; Liu LT; Li H
Chin J Integr Med; 2019 Aug; 25(8):574-581. PubMed ID: 30109588
[TBL] [Abstract][Full Text] [Related]
2. Clinical Experience in Treatment of Alzheimer's Disease with Jiannao Yizhi Formula () and Routine Western Medicine.
Wang HC; Liu NY; Zhang S; Yang Y; Wang ZY; Wei Y; Liu JG; Pei H; Li H
Chin J Integr Med; 2020 Mar; 26(3):212-218. PubMed ID: 32180150
[TBL] [Abstract][Full Text] [Related]
3. Huannao Yicong Formula () regulates γ-secretase activity through APH-1 and PEN-2 gene ragulation pathways in hippocampus of APP/PS1 double transgenic mice.
Wang ZY; Liu JG; Wei Y; Liu MX; Wang Q; Liang L; Yang HM; Li H
Chin J Integr Med; 2017 Apr; 23(4):270-278. PubMed ID: 28120208
[TBL] [Abstract][Full Text] [Related]
4. ABT-126 monotherapy in mild-to-moderate Alzheimer's dementia: randomized double-blind, placebo and active controlled adaptive trial and open-label extension.
Gault LM; Lenz RA; Ritchie CW; Meier A; Othman AA; Tang Q; Berry S; Pritchett Y; Robieson WZ
Alzheimers Res Ther; 2016 Oct; 8(1):44. PubMed ID: 27756421
[TBL] [Abstract][Full Text] [Related]
5. Cognitive Improvement during Treatment for Mild Alzheimer's Disease with a Chinese Herbal Formula: A Randomized Controlled Trial.
Zhang Y; Lin C; Zhang L; Cui Y; Gu Y; Guo J; Wu D; Li Q; Song W
PLoS One; 2015; 10(6):e0130353. PubMed ID: 26076022
[TBL] [Abstract][Full Text] [Related]
6. Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group.
Rogers SL; Doody RS; Mohs RC; Friedhoff LT
Arch Intern Med; 1998 May; 158(9):1021-31. PubMed ID: 9588436
[TBL] [Abstract][Full Text] [Related]
7. The efficacy and safety of donepezil in patients with Alzheimer's disease: results of a US Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial. The Donepezil Study Group.
Rogers SL; Friedhoff LT
Dementia; 1996; 7(6):293-303. PubMed ID: 8915035
[TBL] [Abstract][Full Text] [Related]
8. Effects of Chinese medicine for tonifying the kidney and resolving phlegm and blood stasis in treating patients with amnestic mild cognitive impairment: a randomized, double-blind and parallel-controlled trial.
Miao YC; Tian JZ; Shi J; Mao M
Zhong Xi Yi Jie He Xue Bao; 2012 Apr; 10(4):390-7. PubMed ID: 22500712
[TBL] [Abstract][Full Text] [Related]
9. [A randomized, controlled, double-blind trial of Huannao Yicong capsule in senile patients with mild cognitive impairment].
Li H; Yao MJ; Zhao WM; Guan J; Cai LL; Cui L
Zhong Xi Yi Jie He Xue Bao; 2008 Jan; 6(1):25-31. PubMed ID: 18184542
[TBL] [Abstract][Full Text] [Related]
10. [Effect of electroacupuncture at governor vessel on learning-memory ability and serum level of APP, Aβ
Xia KP; Pang J; Li SL; Zhang M; Li HL; Wang YJ
Zhongguo Zhen Jiu; 2020 Apr; 40(4):375-8. PubMed ID: 32275365
[TBL] [Abstract][Full Text] [Related]
11. Huannao Yicong Decoction () extract reduces inflammation and cell apoptosis in Aβ
Wang Q; Li H; Wang FX; Gao L; Qin JC; Liu JG; Wei Y; Liu MX
Chin J Integr Med; 2017 Sep; 23(9):672-680. PubMed ID: 27022730
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial.
Wilcock GK; Black SE; Hendrix SB; Zavitz KH; Swabb EA; Laughlin MA;
Lancet Neurol; 2008 Jun; 7(6):483-93. PubMed ID: 18450517
[TBL] [Abstract][Full Text] [Related]
13. A Phase 2 clinical trial of PF-05212377 (SAM-760) in subjects with mild to moderate Alzheimer's disease with existing neuropsychiatric symptoms on a stable daily dose of donepezil.
Fullerton T; Binneman B; David W; Delnomdedieu M; Kupiec J; Lockwood P; Mancuso J; Miceli J; Bell J
Alzheimers Res Ther; 2018 Apr; 10(1):38. PubMed ID: 29622037
[TBL] [Abstract][Full Text] [Related]
14. [Chinese herbal medicine for patients with mild to moderate Alzheimer disease based on syndrome differentiation: a randomized controlled trial].
Yu L; Lin SM; Zhou RQ; Tang WJ; Huang PX; Dong Y; Wang J; Yu ZH; Chen JL; Wei L; Xing SL; Cao HJ; Zhao HB
Zhong Xi Yi Jie He Xue Bao; 2012 Jul; 10(7):766-76. PubMed ID: 22805083
[TBL] [Abstract][Full Text] [Related]
15. Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial.
De Jesus Moreno Moreno M
Clin Ther; 2003 Jan; 25(1):178-93. PubMed ID: 12637119
[TBL] [Abstract][Full Text] [Related]
16. The efficacy and safety of the Chinese herbal medicine Di-Tan decoction for treating Alzheimer's disease: protocol for a randomized controlled trial.
Chua KK; Wong A; Kwan PW; Song JX; Chen LL; Chan AL; Lu JH; Mok V; Li M
Trials; 2015 Apr; 16():199. PubMed ID: 25925312
[TBL] [Abstract][Full Text] [Related]
17. Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial.
Lannfelt L; Blennow K; Zetterberg H; Batsman S; Ames D; Harrison J; Masters CL; Targum S; Bush AI; Murdoch R; Wilson J; Ritchie CW;
Lancet Neurol; 2008 Sep; 7(9):779-86. PubMed ID: 18672400
[TBL] [Abstract][Full Text] [Related]
18. A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase IIb Clinical Study to Evaluate the Safety and Efficacy of DHP1401 in Patients with Mild to Moderate Alzheimer's Disease Treated with Donepezil: DHP1401 Randomized Trial in Mild to Moderate Alzheimer's Disease (DRAMA).
Shim Y; Han HJ; Park KW; Kim BC; Park KH; Park MY; Kim HJ; Moon SY; Choi SH; Park KW; Yang DW; Yoon SJ; Kim SY; Youn YC; Choi H; Yoon KE; Cho HJ; Han SH
J Alzheimers Dis; 2022; 87(1):391-403. PubMed ID: 35275529
[TBL] [Abstract][Full Text] [Related]
19. A long-term comparison of galantamine and donepezil in the treatment of Alzheimer's disease.
Wilcock G; Howe I; Coles H; Lilienfeld S; Truyen L; Zhu Y; Bullock R; Kershaw P;
Drugs Aging; 2003; 20(10):777-89. PubMed ID: 12875613
[TBL] [Abstract][Full Text] [Related]
20. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E
J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
